Association of EVI5 Rs11808092, CD58 Rs2300747, and CIITA Rs3087456 Polymorphisms with Multiple Sclerosis Risk: A Meta-analysis

Overview

Journal Meta Gene

Publisher Elsevier

Specialty Genetics

Date 2016 Jun 23

PMID 27331013

Citations 2

Authors

Jiahe Liu

Xu Liu

Yong Liu

Shimin Deng

Hongbin Huang

Qicong Chen

Weidong Liu

Zunnan Huang

Affiliations

Soon will be listed here.

Abstract

Purpose: Multiple sclerosis (MS) is a major demyelinating disease of the central nervous system with a strong genetic component. Previous studies have reported that the association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with the susceptibility to MS. However, the results were inconsistent. Thus, we conducted this meta-analysis to provide a more accurate estimation of the association between any of these polymorphisms and MS risk.

Methods: The PubMed, Embase, Chinese National Knowledge Infrastructure, Wan Fang databases and MSGene were used to search all potentially relevant studies. The odds ratio (OR) with 95% confidence interval (CI) was used to investigate the associations between these three polymorphisms and MS risk.

Results: 16 independent case-control studies from 12 publications were finally included into this meta-analysis. The results showed that EVI5 rs11808092 polymorphism was related with increasing the development of MS under five genetic models (allelic: OR = 1.17, 95% CI = 1.10-1.24, P < 0.01; homozygous: OR = 1.37, 95% CI = 1.18-1.59, P < 0.01; heterozygous: OR = 1.16, 95% CI = 1.07-1.26, P < 0.01; recessive: OR = 1.28, 95% CI = 1.11-1.48, P < 0.01; and dominant: OR = 1.19, 95% CI = 1.11-1.48, P < 0.01). CD58 rs2300747 polymorphism was found to be associated with decreasing MS risk in three genetic models (allelic: OR = 0.86, 95% CI = 0.78-0.94, P < 0.01; heterozygous: OR = 0.85, 95% CI = 0.76-0.94, P < 0.01, and dominant: OR = 0.84, 95% CI = 0.76-0.93, P < 0.01). However, this meta-analysis indicated that CIITA rs3087456 polymorphism was not related to multiple sclerosis.

Conclusions: The mutant alleles of EVI5 rs11808092 polymorphism may increase the susceptibility to MS while those of CD58 rs2300747 polymorphism may decrease MS risk. In addition, CIITA rs3087456 polymorphism might not be associated with MS.

Citing Articles

Analysis of herpesvirus infection and genome single nucleotide polymorphism risk factors in multiple sclerosis, Volga federal district, Russia.

Lezhnyova V, Davidyuk Y, Mullakhmetova A, Markelova M, Zakharov A, Khaiboullina S Front Immunol. 2022; 13:1010605.

PMID: 36451826 PMC: 9703080. DOI: 10.3389/fimmu.2022.1010605.

Association of polymorphism and multiple sclerosis in Malaysia: a pilot study.

Ching Y, Viswanathan S, Mohamed Nor N, Shuib S, Kamarudin B, Mansor S Auto Immun Highlights. 2020; 10(1):13.

PMID: 32257069 PMC: 7065364. DOI: 10.1186/s13317-019-0123-7.

References

Alcina A, Fernandez O, Gonzalez J, Catala-Rabasa A, Fedetz M, Ndagire D . Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis. Eur J Hum Genet. 2010; 18(7):827-31. PMC: 2987353. DOI: 10.1038/ejhg.2009.240. View

Sawcer S, Hellenthal G, Pirinen M, Spencer C, Patsopoulos N, Moutsianas L . Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476(7359):214-9. PMC: 3182531. DOI: 10.1038/nature10251. View

Didonna A, Isobe N, Caillier S, Li K, Burlingame A, Hauser S . A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome. Hum Mol Genet. 2015; 24(24):7151-8. PMC: 5007634. DOI: 10.1093/hmg/ddv412. View

Ting J, Trowsdale J . Genetic control of MHC class II expression. Cell. 2002; 109 Suppl:S21-33. DOI: 10.1016/s0092-8674(02)00696-7. View

De Jager P, Baecher-Allan C, Maier L, Arthur A, Ottoboni L, Barcellos L . The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci U S A. 2009; 106(13):5264-9. PMC: 2664005. DOI: 10.1073/pnas.0813310106. View

Rasmussen H, Kelly M, Clausen J . Genetic susceptibility to multiple sclerosis: detection of polymorphic nucleotides and an intron in the 3' untranslated region of the major histocompatibility complex class II transactivator gene. Hum Immunol. 2001; 62(4):371-7. DOI: 10.1016/s0198-8859(01)00215-4. View

Rubio J, Stankovich J, Field J, Tubridy N, Marriott M, Chapman C . Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun. 2008; 9(7):624-30. DOI: 10.1038/gene.2008.59. View

Martinez A, Sanchez-Lopez M, Varade J, Mas A, Martin M, de Las Heras V . Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis. 2006; 66(3):325-9. PMC: 1855999. DOI: 10.1136/ard.2006.059428. View

Compston A, Coles A . Multiple sclerosis. Lancet. 2008; 372(9648):1502-17. DOI: 10.1016/S0140-6736(08)61620-7. View

10.

Pandit L, Ban M, Sawcer S, Singhal B, Nair S, Radhakrishnan K . Evaluation of the established non-MHC multiple sclerosis loci in an Indian population. Mult Scler. 2010; 17(2):139-43. DOI: 10.1177/1352458510384011. View

11.

Johnson B, Wang J, Taylor E, Caillier S, Herbert J, Khan O . Multiple sclerosis susceptibility alleles in African Americans. Genes Immun. 2009; 11(4):343-50. PMC: 2880217. DOI: 10.1038/gene.2009.81. View

12.

Begg C, Mazumdar M . Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. View

13.

Bashinskaya V, Kulakova O, Kiselev I, Baulina N, Favorov A, Boyko A . GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians. J Neuroimmunol. 2015; 282:85-91. DOI: 10.1016/j.jneuroim.2015.03.015. View

14.

Ramagopalan S, Dyment D, Valdar W, Herrera B, Criscuoli M, Yee I . Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol. 2007; 6(7):604-10. DOI: 10.1016/S1474-4422(07)70132-1. View

15.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

16.

Hoppenbrouwers I, Aulchenko Y, Ebers G, Ramagopalan S, Oostra B, van Duijn C . EVI5 is a risk gene for multiple sclerosis. Genes Immun. 2008; 9(4):334-7. DOI: 10.1038/gene.2008.22. View

17.

ODoherty C, Hawkins S, Rooney M, Vandenbroeck K . The MHC2TA-168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies. Tissue Antigens. 2007; 70(3):247-51. DOI: 10.1111/j.1399-0039.2007.00876.x. View

18.

Shahbazi M, Roshandel D, Omidnyia E, Rshaidbaghan A . Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis. Clin Immunol. 2011; 139(3):277-81. DOI: 10.1016/j.clim.2011.02.012. View

19.

. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 2009; 41(7):824-8. DOI: 10.1038/ng.396. View

20.

Zuvich R, McCauley J, Pericak-Vance M, Haines J . Genetics and pathogenesis of multiple sclerosis. Semin Immunol. 2009; 21(6):328-33. PMC: 2789848. DOI: 10.1016/j.smim.2009.08.003. View